Dana dhuwit saben saham Lantheus Corp (LNTH)

Lantheus Corp - logo grafis emiten LNTH

Lantheus Holdings, Inc. (LNTH) leads in high-precision cardiac and oncology imaging by developing advanced radiopharmaceuticals. Its success relies on Pylarify sales and a stable operating margin, while precision aviation logistics ensure the timely delivery of isotopes to hospitals. Cash per share demonstrates the business's current liquidity, where the current mark equals 10.47, allowing for an assessment of the company's financial cushion.

Lantheus Medical Imaging - Dhuwit awis saben saham LNTH (periode 04.07.2022 - 21.11.2026)

Rincian metrik komprehensif lan analitis lantheus.com (LNTH)

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:Lantheus Holdings, Inc.
Sampel barang Lantheus Holdings, Inc.

The dominance of Pylarify generates significant cash flows for Lantheus Holdings, Inc. (LNTH), which accumulate as liquid reserves per common share. This metric reflects the actual proportion of cash within the capital structure, serving as a guarantee of financial stability and a hedge against inflationary depreciation in the absence of new investments. By evaluating the trend of cash per share, an investor determines the actual value of the liquid collateral backing their investment.